+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Multi Drug Resistance"

Antimicrobial Resistance Surveillance Market by Solution (Kits, System, Surveillance Software, Service), Application (Clinical Diagnostics, Public Health Surveillance), End User (Hospitals, Clinics, Academic, Research Institutes) - Global Forecast to 2028 - Product Thumbnail Image

Antimicrobial Resistance Surveillance Market by Solution (Kits, System, Surveillance Software, Service), Application (Clinical Diagnostics, Public Health Surveillance), End User (Hospitals, Clinics, Academic, Research Institutes) - Global Forecast to 2028

  • Report
  • September 2023
  • 200 Pages
  • Global
From
Asia Pacific Antibiotics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Drug Class; Action Mechanism; and Country - Product Thumbnail Image

Asia Pacific Antibiotics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Drug Class; Action Mechanism; and Country

  • Report
  • June 2020
  • 123 Pages
  • Asia Pacific
From
Current Developments in the Detection and Control of Multi Drug Resistance - Product Thumbnail Image

Current Developments in the Detection and Control of Multi Drug Resistance

  • Book
  • July 2022
21st Century Challenges in Antimicrobial Therapy and Stewardship - Product Thumbnail Image

21st Century Challenges in Antimicrobial Therapy and Stewardship

  • Book
  • November 2020
From
Combination Therapy Against Multidrug Resistance - Product Thumbnail Image

Combination Therapy Against Multidrug Resistance

  • Book
  • April 2020
In Silico Drug Design. Repurposing Techniques and Methodologies - Product Thumbnail Image

In Silico Drug Design. Repurposing Techniques and Methodologies

  • Book
  • February 2019
  • 6 Results (Page 1 of 1)
Loading Indicator

The Multi Drug Resistance (MDR) market is a subset of the pharmaceutical industry that focuses on the development of drugs to treat diseases that have become resistant to existing treatments. MDR drugs are designed to target specific genetic mutations that cause drug resistance, allowing them to be more effective than traditional treatments. These drugs are often used in combination with other treatments to maximize their effectiveness. MDR drugs are used to treat a variety of diseases, including cancer, HIV/AIDS, and bacterial infections. They are also used to treat rare diseases, such as cystic fibrosis and Huntington's disease. The development of MDR drugs is a complex process, requiring extensive research and clinical trials. Some companies in the MDR market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more